Pfizer stock (NYSE: PFE) reported its Q2 results last week, with revenue and earnings comfortably above ours and the street estimates.
Pfizer stock (NYSE: PFE) reported its Q2 results last week, with revenue and earnings comfortably above ours and the street estimates.